GSE125014 enzalutamide prostate gland 1 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE125014_enzalutamide_prostate gland_1_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE125014_enzalutamide_prostate gland_1_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE125014_enzalutamide_prostate gland_1_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE125014_enzalutamide_prostate gland_1_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

ribosomal protein S4 Y-linked 1

Gene

microtubule associated protein 7

Gene

eukaryotic translation initiation factor 1A Y-linked

Gene

lysine demethylase 5D

Gene

ChaC glutathione specific gamma-glutamylcyclotransferase 1

Gene

paternally expressed 3

Gene

thioredoxin domain containing 9

Gene

adrenomedullin

Gene

stanniocalcin 2

Gene

thrombospondin 1

  • Gene

    ribosomal protein S4 Y-linked 1


  • Gene

    microtubule associated protein 7


  • Gene

    eukaryotic translation initiation factor 1A Y-linked


  • Gene

    lysine demethylase 5D


  • Gene

    ChaC glutathione specific gamma-glutamylcyclotransferase 1


  • Gene

    paternally expressed 3


  • Gene

    thioredoxin domain containing 9


  • Gene

    adrenomedullin


  • Gene

    stanniocalcin 2


  • Gene

    thrombospondin 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.